154 related articles for article (PubMed ID: 10482637)
1. Localization of a passively transferred human recombinant monoclonal antibody to herpes simplex virus glycoprotein D to infected nerve fibers and sensory neurons in vivo.
Sanna PP; Deerinck TJ; Ellisman MH
J Virol; 1999 Oct; 73(10):8817-23. PubMed ID: 10482637
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro.
Mikloska Z; Sanna PP; Cunningham AL
J Virol; 1999 Jul; 73(7):5934-44. PubMed ID: 10364346
[TBL] [Abstract][Full Text] [Related]
3. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
4. Difficulties imaging herpes simplex keratitis with fluorescein isothiocynate-labeled anti-HSV-1 antibodies in an ex vivo model.
Novitskaya ES; McGilligan VE; Moore JE; Sharma A; Dean SJ; Moore TC
Cornea; 2009 May; 28(4):421-5. PubMed ID: 19411961
[TBL] [Abstract][Full Text] [Related]
5. Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV.
Sanna PP; De Logu A; Williamson RA; Hom YL; Straus SE; Bloom FE; Burton DR
Virology; 1996 Jan; 215(1):101-6. PubMed ID: 8553581
[TBL] [Abstract][Full Text] [Related]
6. The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice.
Loiacono CM; Taus NS; Mitchell WJ
J Neurovirol; 2003 Jun; 9(3):336-45. PubMed ID: 12775417
[TBL] [Abstract][Full Text] [Related]
7. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
9. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
10. Characterization of polyclonal antibodies to Herpes Simplex Virus types 1 and 2.
Lloyd J; Copaciu R; Yahyabeik A; DeWit C; Cummings K; Lacey M; Su Q
J Histotechnol; 2019 Dec; 42(4):202-214. PubMed ID: 31680648
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
12. Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.
Li L; Li Z; Wang E; Yang R; Xiao Y; Han H; Lang F; Li X; Xia Y; Gao F; Li Q; Fraser NW; Zhou J
J Virol; 2016 Jan; 90(2):790-804. PubMed ID: 26512084
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies directed against a 130K glycoprotein of bovine herpesvirus 2 cross-react with glycoprotein B of herpes simplex virus.
Conraths FJ; Pauli G; Ludwig H
Virus Res; 1988 Apr; 10(1):53-63. PubMed ID: 2837013
[TBL] [Abstract][Full Text] [Related]
14. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
Criscuolo E; Castelli M; Diotti RA; Amato V; Burioni R; Clementi M; Ambrosi A; Mancini N; Clementi N
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867302
[TBL] [Abstract][Full Text] [Related]
15. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
[TBL] [Abstract][Full Text] [Related]
16. The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.
Lubinski JM; Lazear HM; Awasthi S; Wang F; Friedman HM
J Virol; 2011 Apr; 85(7):3239-49. PubMed ID: 21228231
[TBL] [Abstract][Full Text] [Related]
17. Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8
Lahmidi S; Yousefi M; Dridi S; Duplay P; Pearson A
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490594
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants.
Liljeqvist JÅ; Trybala E; Hoebeke J; Svennerholm B; Bergström T
J Gen Virol; 2002 Jan; 83(Pt 1):157-165. PubMed ID: 11752712
[TBL] [Abstract][Full Text] [Related]
19. Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1.
Grabowska A; Jameson C; Laing P; Jeansson S; Sj Gren-Jansson E; Taylor J; Cunningham A; Irving WL
J Gen Virol; 1999 Jul; 80 ( Pt 7)():1789-1798. PubMed ID: 10423148
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential.
De Logu A; Williamson RA; Rozenshteyn R; Ramiro-Ibañez F; Simpson CD; Burton DR; Sanna PP
J Clin Microbiol; 1998 Nov; 36(11):3198-204. PubMed ID: 9774565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
